ASAP (Aligning Science Against Parkinson's) initiative funding stream

Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s.

With scale, transparency, and open access data sharing, the initiative aims to accelerate the pace of discovery, and inform the path to a cure.

Funding opportunities through the ASAP initiative first opened in 2019. The ASAP initiative currently awards grants of up to $3 million over three years via its Scientific Track.

The ASAP initiative will accept applications to support multidisciplinary research teams to form the ASAP Collaborative Research Network. ASAP seeks to fund research projects to address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression.

Applications must focus on one of the following scientific themes:

  • PD Functional Genomics
  • Neuro-Immune Interactions
  • Circuitry and Brain-Body Interactions
  • Progression: A Cross-Cutting Theme

The request for applications is open to international organisations including public and private non-profit groups, agencies of the U.S. federal government, and for-profit entities. Applications must be submitted by multidisciplinary, multi-institutional research teams consisting of three to five investigators.

ASAP has now opened the call for Letters of Intent (LOIs). 

  • LOIs Deadline: 20 March 2025 (6PM ET)
  • Invitation to Submit Full Proposal: Week commencing on 2 June 2025
  • Full Proposal Deadline: 7 August 2025
  • Invitation to Interview: Earliest notification during the week of 3 November 2025
  • Finalist Virtual Interviews: November 2025
  • Anticipated Award Announcement: January 2026
  • Award Amounts: Awarded teams will receive funding of up to $3M per year for three years
  • Anticipated Project Start Date: June 2026

For more details and to apply, visit the ASAP website.

Discover more about ASAP

Learn more about how ASAP is coordinating a new approach to basic research into Parkinson’s.